Future Growth of Isothermal Nucleic Acid Amplification Technology MarketPosted by snehal shaha on November 24th, 2023 The growth of the market is attributed the growing funding initiatives for molecular diagnostics & infectious diseases, and recent launches of INAAT consumables by prominent market players. However, the unfavorable reimbursement scenario for in vitro diagnostic tests is a major factor restraining market growth. The isothermal nucleic acid amplification technology market is expected to grow at a CAGR of 9.2% during the forecast period. The report Isothermal Nucleic Acid Amplification Technology Market is projected to reach USD 6.8 billion by 2028 from USD 4.4 billion in 2023, at a CAGR of 9.2% during the forecast period. KEY MARKET DYNAMICS 1 DRIVERS 1 Recent launches of INAAT consumables by prominent market players 2 Growing funding initiatives for molecular diagnostics & infectious disease diagnostics 3 High prevalence of infectious diseases 2 RESTRAINTS 1 Unfavorable reimbursement scenario for in vitro diagnostic tests 3 OPPORTUNITIES 1 INAAT tests as point-of-care tools 2 Start-ups focusing on INAAT 4 CHALLENGES 1 Dominance of PCR Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=839 Market Segmentation
Regional Analysis North America is expected to account for the largest share of the global INAAT market, followed by Europe in 2022. The largest share of the North American market is attributed to the presence of a leading market players, growing burden of infectious diseases and availability of R&D funding for molecular diagnostics. Request for Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=839 Recent Developments
Top Key Players The prominent players operating in INAAT market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK). Factors influencing the regional dynamics of the INAAT market include healthcare infrastructure, research funding, disease prevalence, regulatory environment, and the presence of key market players. the market was poised for growth globally, with increasing applications in infectious disease diagnostics, point-of-care testing, and environmental monitoring. Like it? Share it!More by this author |